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Background: The relationship between infection with high-risk human papillomavirus (HPV) and cervical cancer is
transforming cervical cancer prevention. HPV tests and vaccinations have recently become available. In Ireland, as
elsewhere, primary care practitioners play a key role in prevention. ATHENS (A Trial of HPV Education and Support)
aims to develop a theory-based intervention to support primary care practitioners in their HPV-related practice.
This study, the first step in the intervention development process, aimed to: identify HPV-related clinical behaviours
that the intervention will target; clarify general practitioners’ (GPs’) and practice nurses’ roles and responsibilities;
and determine factors that potentially influence clinical behaviour. A secondary objective was to informally assess
the utility of the Theoretical Domains Framework (TDF) in understanding clinical behaviours in an area with an
evolving evidence-base.
Methods: In-depth semi-structured telephone interviews were conducted with GPs and practice nurses. The topic
guide, which contained open questions and HPV-related clinical scenarios, was developed through literature review
and clinical experience. Interview transcripts were content-analysed using the TDF as the coding framework.
Results: 19 GPs and 14 practice nurses were interviewed. The major HPV-related clinical behaviours were: initiating
a discussion about HPV infection with female patients; offering/recommending HPV vaccination to appropriate
patients; and answering patients’ questions about HPV testing. While the responsibility for taking smears was
considered a female role, both male and female practitioners dealt with HPV-related issues. All 12 theoretical
domains arose in relation to HPV infection; the domains judged to be most important were: knowledge, emotion,
social influences, beliefs about capabilities and beliefs about consequences. Eleven domains emerged in relation to
HPV vaccination, with beliefs about consequences, social influences, knowledge and environmental context and
resources judged to be the most important. Nine domains were relevant to HPV testing, with knowledge and beliefs
about capabilities judged to be the most important.
Conclusions: The findings confirm the need for an intervention to support primary care practitioners around HPV
and suggest it should target a range of theoretical domains. The TDF proved valuable in analysing qualitative data
collected using a topic guide not specifically designed to capture TDF domains and understanding clinical
behaviours in an area with an evolving evidence-base.
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More than 40 strains of human papillomavirus (HPV)
are sexually transmitted and infect mucosal surfaces of
the lower genital area [1]. Around 15 of these strains,
including HPV16 and HPV18, are known as ‘high-risk’
types because they are a necessary cause of cervical
cancer [2]. These high-risk types are common [3],
asymptomatic, and cleared by most women in a few
months; in some women, however, persistent infection(s)
can lead to cervical pre-cancer and cancer [1].
It is generally accepted that, in the near future, cervical
screening will be based on testing for infection with
high-risk HPV types, rather than on conventional cyto-
logical smears [4-6]. Compared to smears, HPV testing
(which can be conducted on residual smear samples) has
higher negative predictive value and higher sensitivity
for the detection of pre-cancer [7] making HPV-based
screening likely to be effective [8,9] and cost-effective
[10,11]. In addition, two prophylactic HPV vaccines have
been developed [12]. For both vaccines, the vaccination
schedule involves three doses at intervals within a six-
month period and is most effective when administered
before HPV exposure (i.e., among the sexually naive).
Organised vaccination, together with screening, could
prevent most cervical cancers [13].
Ireland, which has a mixed public-private health-
care system, is at the forefront of this transformation
in cervical cancer prevention. A national screening
programme, CervicalCheck, was rolled-out in autumn
2008. The programme invites women aged 25 to 60 for
a free smear in primary care every 3 to 5 years [14].
Prior to this, a woman could obtain a smear from her
general practitioner (GP) or ‘Well Woman’ clinic for
around €50. HPV testing is available through some prac-
tices and Well Woman clinics. CervicalCheck is cur-
rently introducing HPV testing in the follow-up of
women treated for pre-cancer and is considering other
uses, for example as a primary screening tool. HPV
vaccination was licensed in males and females aged 9 to
26 in 2006, and can be purchased in primary care for
around €600. In autumn 2010, a national schools-based
vaccination programme started, providing free vaccin-
ation to girls aged around 12 [15]. These developments
have been accompanied by changes in primary care,
notably a move from single-doctor to multi-doctor prac-
tices supported by practice nurses. Traditionally, GPs
were the primary smear takers, but practice nurses now
play an important role in smear taking [16] and perform
around one-half of the smears within CervicalCheck.
In addition to providing smear tests, GPs and practice
nurses are likely to be key sources of information and
advice for patients on HPV infection, vaccination, and
testing. For women, their GPs’ attitude influences their
own prevention behaviours [17,18]. Moreover, healthcareprofessionals’ compliance with, and encouragement of,
HPV vaccination is crucial in achieving high vaccination
rates [19]. Therefore, GPs’ and practice nurses’ clinical
practices in relation to HPV will impact on the success
of cervical cancer prevention strategies.
Little is known about what influences HPV-related
clinical practice. Most research has focussed on prac-
titioners’ knowledge, and while this is an important pre-
dictor of clinical behaviour, it is unlikely to be the sole
influence [20,21]. A 2004 US family doctors’ survey
found that substantial proportions were unaware of
information on HPV infection relevant for patient coun-
selling [22]. A 2007 survey of GPs in Ireland, using the
same instrument (see Additional file 1), found lower
knowledge levels than in the US survey [23], and import-
ant gaps in knowledge about HPV vaccination, consist-
ent with findings from elsewhere [24-27]. More than
95% of GPs desired national guidelines or policy on
HPV vaccination and testing. HPV infection knowledge
predicted HPV vaccination intentions: GPs with higher
knowledge scores were significantly more likely to be
willing to vaccinate sexually naive girls aged under 16
than those with lower knowledge scores. A 2007 study
among US family doctors, found the Theory of Planned
Behaviour [28] variables intentions, subjective norms
(perceptions about whether others approve of vaccin-
ation), and perceived behavioural control (perceptions
about whether the decision to vaccinate is within the
control of the doctor) influenced HPV vaccination be-
haviour [29]. No studies have investigated determinants
of practice nurses’ clinical behaviours in this field.
ATHENS (A Trial of HPV Education and Support),
which is being conducted under the umbrella of the
CERVIVA research consortium (www.cerviva.ie) aims to
develop a theory-based intervention to support primary
care practitioners in their practice in relation to HPV
infection, vaccination, and testing. The current study is
the first step in this intervention development process.
The primary aims were to: identify HPV-related clinical
behaviours that the intervention will target; clarify roles
and responsibilities of GPs and practice nurses in these
areas; and determine what influences these clinical beha-
viours. Because little is known about practice, or poten-
tially relevant psychological theories, we used qualitative
methods to generate data with richness and depth, and
analysed this using the Theoretical Domains Framework
(TDF) [30]. As the TDF was originally developed to aid
understanding of clinical behaviours around evidence-
based guidelines, a secondary objective was to reflect the
utility of the TDF in a way that may inform other
researchers who are considering using it.
This article is one of a series documenting the devel-
opment and use of the TDF to advance the science of
implementation research. An overview of the articles
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Methods
Participants and recruitment
GPs and practice nurses working in Ireland were eligible
to participate. GPs were recruited from a group of 145
participants in the 2007 survey [23], who were originally
sampled from a national database and had indicated they
were potentially willing to assist with further research.
The group was diverse in terms of personal and practice
characteristics and HPV infection knowledge and vac-
cination attitudes (in 2007). A purposive sample was
recruited from this group, with strata defined in terms
of variables that had been found in the 2007 survey
to be strongly associated with attitudes towards smear
taking and HPV vaccination, namely: gender, years since
graduation, area of practice location, and HPV infection
knowledge score in 2007 (questions shown in Additional
file 1). GPs were approached by post, in batches in a
random order, and invited to take part in an interview
about their views and experiences of cervical cancer pre-
vention. Those interested returned a reply slip, and the
study co-ordinator (LAMcS) contacted them to arrange
an interview. Non-respondents received up to two
reminder letters. As interviews progressed, particular
attention was paid to recruiting GPs in unfilled strata.
Since there is no national database of practice nurses,
two approaches were used to identify potential partici-
pants. Firstly, all attendees at the annual national Irish
Practice Nurses Association conference received a flyer
and were invited to return this if they were interested in
taking part. Secondly, invitation packs, compiled by the
study team, were provided to professional development
co-ordinators (PDCs) in six of the seven administra-
tive areas across Ireland. The PDCs were each asked to
select, at random, five nurses in their area to whom to
send the packs. Nurses who returned the reply slip were
contacted for interview. The only sampling stratum was
area of practice and, as recruitment progressed, efforts
were focussed on ensuring that nurses were recruited
from urban and rural areas across the country.
Ethical approval was obtained from the ethics commit-
tee of the Irish College of General Practitioners. Partici-
pants provided informed consent.
Procedures
Interviews were conducted by telephone by the study
co-ordinator (LAMcS) and guided by a topic guide
(Additional file 2). The topic guide was developed with
input from a multidisciplinary team including investiga-
tors (LAMcS, LS, and SUD), the head of smear taker
training at CervicalCheck, a practicing GP and practice
nurse. It was informed by: literature review; a groupdiscussion with the CervicalCheck smear taker training
unit, who provide training sessions and a telephone
helpline for GPs and practice nurses; discussions with
the HPV vaccination team at the HSE National Immu-
nisation Office and observation at one of their open
meetings for GPs and practice nurses; and informal dis-
cussions with primary care practitioners. The guide
included open questions and clinical scenarios designed
to elicit information about HPV-related clinical beha-
viours, roles, and responsibilities in primary care, and
drivers of clinical behaviours. It was organised in four
clinical areas: cervical screening/smear taking, HPV
infection, HPV vaccination, and HPV testing. The topic
of cervical screening/smear taking was not the main
focus of the study, but was included to set the context of
the discussions about HPV. Participants were invited to
discuss their experiences, views, barriers, and facilitators
to practice, and support needs in each clinical area. The
clinical scenarios covered HPV-related issues that could
arise in practice and, potentially, present difficulties or
challenges. Interviewees were asked to describe what
they would do in each situation and how easy/difficult
they would find it to handle. During the interview the
interviewer chose which scenarios to present; these cov-
ered topics that had not already been raised by the inter-
viewee, with the aim of eliciting as much information
as possible.
Recruitment continued until new issues ceased to
emerge for GPs and practice nurses separately. Inter-
views lasted 16 to 50 minutes and were audio-recorded;
three participants declined to be recorded, and so
detailed notes were taken instead. Recordings were tran-
scribed verbatim and anonymised.
Analysis
Content analysis was conducted following the frame-
work analysis approach [32,33]. GP and practice nurse
interviews were analysed together. The four clinical
areas were considered separately. Two investigators
(LAMcS, LS) read and re-read all transcripts, independ-
ently coded these, combined codes into subthemes and
allocated these, and direct quotes from participants, to
one of the 12 theoretical domains/themes of the TDF
[30]. They held regular discussions to resolve disagree-
ments and reach consensus and discussed uncertainties
with a third investigator (JJF). To ensure analytical
rigour, a second iteration of this process was performed,
with re-review of transcripts to identify any important
quotes or subthemes missed or misallocated. It was
noted whether subthemes arose solely among GPs, prac-
tice nurses or both. The final synthesis and interpret-
ation involved considering each theme/domain and
subtheme in the context of the whole set of interviews.
The strongest/dominant themes/domains were those:
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themes were identified; which were discussed at greatest
length; and/or which were judged by the investigators to
be invested with considerable intensity, passion, or senti-
ment by practitioners.
Although interviews covered cervical screening, the
results reported here concentrate primarily on HPV
infection, vaccination, and testing. Illustrative quotes have
been provided to supplement narrative descriptions.
Results
A total of 145 GPs were contacted, and telephone inter-
views were conducted with 19. Of the 30 practice nurses
invited to take part through PDCs, ten were interviewed;
a further four practice nurses, recruited at the annual
conference, were also interviewed. Table 1 summarises
participants’ characteristics.
Clinical behaviours
A limited number of HPV-related clinical behaviours
were identified. As regards HPV infection, the key
behaviour was initiating a discussion on this topic with
female patients. This was more often done if the practi-
tioner had a relevant ‘opening,’ such as a patient with
HPV reported on her smear result, or a patientTable 1 Characteristics of practitioners interviewed
Gender Female
Male
Healthboard area HSE Mid-Eas
HSE North-Ea
HSE Souther
HSE Western
Location of practice City
Other
Solo GP practice Yes
No
Practice nurse Yes
No
Years since graduation * <10 years
10-19 years
20-39 years
HPV information knowledge score * 1 High (11+)
Medium (7-1
Low (<7)
HPV vaccine attitude * Positive
Negative / n
* Data from 2007 GP survey (Murphy et al., 2008) [23].
1 Number of 13 factual questions about HPV infection that were answered correctly
n/a = not available.presenting with genital warts. A few participants, mainly
practice nurses, reported routinely mentioning HPV
infection to women attending for smears. For HPV
vaccination, three behaviours were identified: offering/
recommending vaccination to appropriate patients; dis-
cussing vaccination when raised by a patient; and
administering the vaccine. The first of these was the
most common behaviour. HPV testing was very rare
among practitioners and answering patients’ questions
was the most important behaviour in this regard.
Roles and responsibilities
Taking smears was considered a predominantly female
role with responsibility falling on female GPs and prac-
tice nurses, who frequently stated that patients should
always have the option of a female smear taker. Male
GPs were less likely to perform smears and made com-
ments like ‘I do an occasional one when a patient
requests it.’
In contrast, HPV infection was discussed with patients
by both male and female GPs and practice nurses.
Similarly, responsibility for behaviours relating to HPV
vaccination and HPV testing fell within the remit of
both GPs and practice nurses. Sometimes, a GP
described discussing HPV vaccination with patients andGPs Practice nurses
13 14
6 0
tern 4 3
stern 3 4
n 7 0
5 7
6 6
13 8
6 7
13 7
16 -
3 -
2 n/a
2 n/a
14 n/a
5 n/a
0) 10 n/a
3 n/a
10 n/a
eutral 7 n/a
(Additional file 1).
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the practice nurse for the two subsequent doses.
Factors that may influence clinical behaviours: HPV
infection
All 12 theoretical domains played a role in relation
to discussing HPV infection with patients (Table 2).
Memory attention and decision processes was least
frequently raised, being mentioned by a single partici-
pant. The strongest domains were knowledge, emotion,
social influences, beliefs about consequences and beliefs
about capabilities.
The knowledge domain had several layers. First, practi-
tioners described a general lack of knowledge and need
for more information. Second, the evidence-base was per-
ceived as rapidly evolving, and practitioners reported diffi-
culty keeping up-to-date. Third, practitioners questioned
the credibility of some information sources. For example,
they noted that much of the information on HPV came
from pharmaceutical companies, and they considered it to
be biased. In contrast, participants expressed confidence
in CervicalCheck as an information source not just as
regards smears, but also in relation to HPV. As regards
emotion, there was a general belief that the whole area of
HPV is ‘sensitive’ and ‘awkward’ as it relates to sexual be-
haviour. Practitioners were concerned about patient em-
barrassment and, for some, their own embarrassment.
The strength of the emotions involved led practitioners to
adopt coping strategies such as being ‘careful’ in what they
said, ‘tiptoeing’ around the topic, or avoiding it altogether.
Patient lack of interest or knowledge was given as an-
other reason for not discussing HPV infection (social
influences). In addition, some practitioners were reluctant
to raise the topic because they felt it might discourage
women from having smears (beliefs about consequences).
In relation to beliefs about capabilities, both GPs and
practice nurses indicated that they found it difficult to ini-
tiate a discussion on HPV infection without some kind of
‘opening,’ such as a direct question from the patient.
As regards the skill domain, GPs observed that they
found it difficult to explain HPV in a way that patients
could understand. Practice nurses observed that discuss-
ing HPV infection could be seen as passing judgement
on an individual’s sexual behaviour, which would be pro-
fessionally inappropriate (social/professional role and
identity). In terms of motivation and goals, some GPs
questioned the need to discuss HPV infection with
patients at all because the infection can resolve on its
own and/or there is no treatment. A lack of time in
consultations and lack of aids for discussion were noted
in regard to environmental context and resources. Some
practitioners recognised opportunities to raise the topic
with patients (e.g., when a patient presented with genital
warts or asked for a prescription for the contraceptivepill) (behavioural regulation). Overall, however HPV
infection was not widely discussed with patients (nature
of the behaviour).
Factors that may influence clinical behaviours: HPV
vaccination
The only theoretical domain that did not emerge in rela-
tion to HPV vaccination was memory, attention and
decision processes (Table 3). The dominant domains were
beliefs about consequences, social influences, knowledge
and environmental context and resources.
Some practitioners believed that HPV vaccination was
effective and safe, but others had concerns about side
effects (beliefs about consequences). For example, some
raised the case of a schoolgirl in the UK who died
shortly after receiving the vaccine in 2009. In general,
practitioners who had daughters were more likely to
have a positive attitude towards HPV vaccination (social
influences). Others perceived that parents would think
that HPV vaccination would encourage promiscuity in
their children, and negative media publicity was cited by
some as a reason for not discussing it with patients. The
same knowledge issues arose for HPV vaccination as
for HPV infection (i.e., lack of knowledge, need for
more information, and credibility of information sources).
The evolving evidence base emerged as especially challen-
ging in relation to practice. For example, practitioners
expressed considerable uncertainty over whether to vac-
cinate sexually active girls. Few were clear or certain of
what to do when faced with this, and other related situa-
tions, in the clinic. Others were certain about what they
would do and why, but their reported practice conflicted
with current evidence. In relation to environmental con-
text and resources, the major barrier to practitioners
recommending HPV vaccination to patients was cost;
for most practitioners this was their primary concern
about vaccination.
Linked to cost, practitioners perceived that there was
an ethical difficulty associated with recommending to
patients something that the practitioner knew patients
could not afford (social/professional role and identity).
Some practitioners mentioned that they were attempting
to provide the HPV vaccine at a cheaper price (e.g., by
buying in bulk, or forming a buying consortium with
other practices) (behavioural regulation). Some practi-
tioners had experienced a consultation about HPV vac-
cination where both mother and daughter were present
and this was described as particularly ‘tricky’ to manage
(skill) and as a ‘minefield’ (emotion). In addition, some
noted that it could be difficult to determine whether
a patient had been sexually active (skill). In terms of
beliefs about capabilities, concerns were expressed
about the ‘newness’ of the vaccines. Finally, some
practitioners did not see patients in the relevant age
Table 2 Factors influencing behaviours related to HPV infection
Theme / construct domain Subtheme / specific belief Practitioner * Sample quote
GPs Practice
nurses
1. Knowledge Don't know enough about it ✓ ✓ ‘Probably well the HPV now I have to say
I’m not au fait as I say. . .’
- Practice nurse 5003It’s an evolving area so it’s hard to keep up to speed ✓ ✓
Not enough information available on it - ✓
Credibility of information sources ✓ ✓
2. Skill Difficulty initiating a discussion on
HPV infection with a patient
✓ ✓ ‘We try and normalise the whole
thing by saying, you know, if we
took blood tests off everybody in
the clinic you’d find something like
80% of us had evidence of HPV
infection at some point in the past’
- GP 0140
Ability to ‘normalise’ HPV infection
when talking to patients
✓ ✓
Difficulty explaining HPV infection in
a way that patients can understand
- ✓
3. Social / professional
role and identity
Don’t want to pass judgement on
patients’ sexual behaviours
- ✓ ‘It’s a very mmm difficult situation and
you don’t want to lay any blame
- Practice nurse 5023
4. Beliefs about capabilities Difficulty dealing with awkward or sensitive situations ✓ - ‘There is difficulty because it’s often mmm
it very much depends on the context. You
know, if mmm if the relationship has broken
down or if they have suspicions, they can be
a very distressing for women to mmm ask
those questions’
- GP 0058
Easier to discuss with patients who are
open or interested
✓ ✓
More likely to discuss HPV infection with patients if:
Already doing a smear - ✓
Patient asks for a prescription for ‘the pill’ ✓ -
Patient presents with genital warts ✓ -
5. Beliefs about
consequences
When discussing HPV infection, patients might: ‘You don’t know whether by highlighting
it [HPV infection] that people might stop
coming for smears
in case it’s positive’
-Practice nurse 5002
Get embarrassed ✓ ✓
Be put off having smears - ✓
Think they have a sexually transmitted disease - ✓
Think their partner is being unfaithful - ✓
6. Motivation and goals Don’t think it’s necessary to discuss
HPV infection with patients
✓ ✓ ‘I wouldn’t see any reason to
[talk about HPV infection]’
-GP 0072
Discussing HPV infection with patients is important ✓ -
7. Memory, attention and
decision processes
Topic is not at the forefront of the practitioner’s mind ✓ - ‘It’s not sort of, of hopping on to the
top of my mind....’
-GP 0090
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Table 2 Factors influencing behaviours related to HPV infection (Continued)
Theme / construct domain Subtheme / specific belief Practitioner * Sample quote
GPs Practice
nurses
8. Environmental context
and resources
Don't have enough time for discussion ✓ ✓ ‘I suppose maybe to have more aids
in very simple descriptions in
different languages. . .it’s simple things
that I draw out and explain to people.
I don’t have that. I suppose it’s something
we need to get together maybe and work on’
- Practice nurse 5001
Need aids for discussion - ✓
Need leaflets about HPV to give to patients - ✓
9. Social influences Patients don't know anything about it ✓ ✓ ‘I would say that most people coming
in for cervical screening do not
understand or even know the
association of HPV to it. . . They do
not associate HPV and cervical cancer
in any way whatsoever’
- Practice nurse 5043
Patients don't want to know about it ✓ ✓
Need for more publicity ✓ -
10. Emotion Sensitive topic because it's about patients'
sexual behaviour
✓ ✓ ‘Well I mean the bottom line is that
I think I’m em, along with most of
my colleagues, are avoiding the
subject. Because we know damn well
that it’s about you know hhh you
know behaviour you know sexual
behaviour. And I mean it’s associated
with sleeping with the wrong guy.....
I think we’re avoiding. I think you’re
right, we’re avoiding the topic cos we
don’t want to go near it because it’s
a can of worms’
- GP 0034
The practitioner might get embarrassed ✓ ✓
11. Behavioural regulation Recognising opportunities to raise topic with patients ✓ ✓ ‘I try to work it [HPV infection] in
sometimes when I’m talking to them
initially about contraception and if
they’re using the pill and stuff like that.’
- GP 0026
Having aids for the discussion available - ✓
Having leaflets available to give to patients ✓ ✓
Having a clear plan of what to say ✓ ✓
12. Nature of the behaviour Don't routinely bring HPV infection up
with patients
✓ ✓ ‘It’s not something that I on a regular
basis discuss with people. . .’
- Practice nurse 5043
* ✓ =Mentioned by at least one practitioner.
- = Not mentioned by any practitioners.
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feel that HPV vaccination was necessary (motivation
and goals).
Factors that may influence clinical behaviours: HPV
testing
Nine of the 12 theoretical domains emerged in rela-
tion to HPV testing. The dominant ones were know-
ledge and beliefs about capabilities (Table 4). Fewersubthemes surfaced for HPV testing than for the
other clinical areas.
In terms of knowledge, there was very limited awareness
of HPV testing and both GPs and practice nurses were un-
clear about what testing involved, how it was done and
whether it was available in Ireland. Practitioners observed
that there was a need for HPV testing guidelines or man-
agement algorithms, and these would make them more
likely to consider offering testing (beliefs about capabilities).
Table 3 Factors influencing behaviours related to HPV vaccination
Theme / construct domain Subtheme / specific belief Practitioner * Sample quote
GPs Practice
nurses
1. Knowledge Not enough information
available about it
- ✓ ‘I suppose the big difficulty with it
really is mmm what to do with girls
who are mmm maybe that little bit
older..... You’re not quite sure if they
have had sexual encounters or not
and whether it’s still worthwhile
giving it or not’
- GP 0058
Rapidly changing area - ✓
Uncertainty over how long
the protection afforded by
vaccination will last
✓ ✓
Uncertainty over whether to
vaccinate older / sexually
active girls or women
✓ -
Uncertainty over whether to
vaccinate boys
✓ ✓
Most of the information comes
from pharmaceutical companies
and is viewed as biased
✓ ✓
2. Skill Difficulty of dealing with a
consultation where both mother
and daughter are present (and/or
mother asking about vaccination
for daughter)
✓ ✓ ‘It’s quite a tricky consultation
[when mother and daughter
are both present] and you’re
very aware of everybody’s,
the confidentiality issues for
the girl, mmm for you know
that mum who’s come with her,
for all of that type of thing’
- Practice nurse 5001
Difficulty assessing whether
a patient has been sexually active
✓ ✓
3. Social / professional role and
identity
Feel out of touch (because HPV
vaccination programme is being
delivered through schools)
- ✓ ‘You see it’s very difficult and I
find it’s quite difficult since
most of my patients are GMS}
and in many of these houses
there’ll be a few girls, and I
know the people can’t afford
the bloomin stuff ....’
- GP 0090
4. Beliefs about capabilities Practitioners are not comfortable
discussing HPV vaccination
✓ - ‘It’s a bit too new probably
compared to some of the other,
you know the baby vaccines
that are out like they’re going
donkeys years now and they
seem fairly safe. I’m sure the
other two [HPV vaccines] are
as well, but I can’t guarantee it’
- Practice nurse 5020
The vaccine is too new to be
considered in primary care
- ✓
5. Beliefs about consequences HPV vaccination can cause
serious side effects
✓ ✓ ‘Are you allowing them to be
more sexually active by giving
them the vaccine. .... I must
admit personally speaking
initially when I first saw I was
oh my goodness you know
girls will become more
promiscuous’
- Practice nurse 5040
Vaccination might encourage
promiscuity
✓ ✓
Belief that vaccine is effective ✓ ✓
Belief that vaccine is safe ✓ ✓
6. Motivation and goals Don't think HPV vaccination
is necessary
✓ - ‘I don’t know now......how much
it’s [HPV vaccination] warranted’
- GP 0086
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Table 3 Factors influencing behaviours related to HPV vaccination (Continued)
Theme / construct domain Subtheme / specific belief Practitioner * Sample quote
GPs Practice
nurses
7. Memory, attention and decision
processes
- - - -
8. Environmental context and
resources
The cost is very high ✓ ✓ ‘I think the price is astronomical.
And outrageous. . .’
- GP 0034
It would involve a lot of
extra work for GPs to
provide HPV vaccination
✓ -
HPV vaccine is not stocked
in the surgery
✓ -
9. Social influences If practitioner has a daughter
they would vaccinate her
✓ ✓ ‘If it was my daughter I’d do it
[vaccinate her]’
- GP 0016
Patients don't know anything
about HPV vaccination
✓ ✓
Parents don't want to know
that their children are sexually
active
✓ ✓
There has been a lot of
negative publicity about HPV
vaccination
✓ ✓
10. Emotion Nervousness about managing
an HPV vaccination consultation
when both mother and daughter
are present
✓ ✓ ‘That can be a little bit of a
minefield there especially if
you’ve got the mother and
daughter in front of you’
- GP 0026
11. Behavioural regulation Sourcing vaccine at a cheaper price ✓ ✓ ‘We got together as a group. . . and
we sourced it as cheaply as we
could because we bought it as a
group so we got a group discount’
- Practice nurse 5001
Having written information
available to provide to patients
✓ ✓
Having posters advertising that
the vaccine is available in the
surgery / waiting rooms
✓ ✓
12. Nature of the behaviour Don't see patients in the
relevant age group
✓ ✓ ‘I actually don’t see very many young
you know, at the ages where I could
see them around 12 or 13. . . I so
rarely see children now’
- GP 0092
* ✓=Mentioned by at least one practitioner.
- = Not mentioned by any practitioners.
§ Patients who have access to free GP appointments and prescriptions by having a means-tested medical card.
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felt that there was uncertainty around its clinical
benefit (beliefs about consequences). Emotion emerged
in relation to professional embarrassment associated
with not being able to answer patients’ questions about
HPV testing.Discussion
Roles and responsibilities
A striking finding of the study was that male GPs had
moved away from responsibility for smear taking; this was
seen to be a predominantly female role. Furthermore, in
recruiting to the study, it was particularly difficult to get
Table 4 Factors influencing behaviours related to HPV testing
Theme / construct domain Subtheme / specific belief Practitioner * Sample quote
GPs Practice
nurses
1. Knowledge Not enough information
available about it
✓ ✓ ‘I didn’t even know that it [HPV testing]
was available. . . Whatever it is whether
it’s a urine or a swab. . . Just don’t
have the knowledge at all’
- Practice nurse 5003
Don't know anything about it ✓ ✓
2. Skill - - - -
3. Social / professional role and identity Topic not covered in
practitioner's training
- ✓ ‘That wasn’t brought up inmy training
or any of our updates’
- Practice nurse 5018
4. Beliefs about capabilities The test is too new to
implement in routine practice
✓ ✓ ‘We don’t have any algorithm for the
management of people with HPV’
- GP 0140
Would be more likely to
discuss HPV testing if:
There were guidelines /
management algorithm
✓ ✓
There was a reliable source
to whom practitioners
can refer questions
✓ -
5. Beliefs about consequences HPV testing provides no
clinical benefit
✓ ✓ ‘I’m not sure there’s any point, I can’t
see the point in it really. It doesn’t seem
to add an awful lot to [the treatment
plan for women with cervical cancer],
like given that you’re going to come up
with a positive or negative test result
to just HPV in geneeral mmm it doesn’t
seem to add anything’
- GP 0133
6. Motivation and goals HPV testing would be useful
in primary care
✓ - ‘I think it would be good to provide
HPV testing’
- GP 0129
7. Memory, attention and decision processes - - - -
8. Environmental context and resources HPV testing costs too much ✓ ✓ ‘From what I understand it’s
very expensive’
- Practice nurse 5018
9. Social influences More publicity is needed to
encourage women to have
a HPV test
✓ - ‘For the public to come forward
[for HPV testing] a media campaign
is always very good because if they
read something in the daily papers
they’ll take heed of it. They won’t
take heed of us advising them a lot’
- GP 0086
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Table 4 Factors influencing behaviours related to HPV testing (Continued)
Theme / construct domain Subtheme / specific belief Practitioner * Sample quote
GPs Practice
nurses
10. Emotion The practitioner could be
embarrassed by not having
answers to patients
questions about HPV testing
✓ - ‘It’d be very difficult because it’d
be mortifying not to have the
answers straight away’
- GP 0034
11. Behavioural regulation - - - -
12. Nature of the behaviour HPV testing is uncommon
in Ireland
- ✓ ‘I don’t think it’s done an awful
lot in Ireland’
- Practice nurse 5020
* ✓=Mentioned by at least one practitioner.
- = Not mentioned by any practitioners.
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prevention as outside their remit. This means that practice
nurses and female GPs may have more opportunity to
raise HPV infection, vaccination, and testing with patients
(e.g., while they are conducting smears). However, patients
may ask a male GP questions about HPV, outside of the
screening setting. Thus, it is important that male GPs keep
up-to-date with developments around HPV and, specific-
ally in relation to ATHENS, both male and female GPs
should be targeted by any intervention in the area of
HPV-related clinical practice.
Factors that may influence clinical behaviours
All theoretical domains emerged as influences on clin-
ical practice. Only one—memory attention and decision
processes—did not play a significant role but was
mentioned by one participant in relation to one clinical
behaviour. Even for HPV testing, which was very un-
common, nine of the domains emerged as potential
influences on practice. This perhaps reflects how com-
plex practitioners consider the topic of HPV to be. Some
domains surfaced more strongly and these are discussed
below.
Emotion
Various studies show that women consider HPV a sensi-
tive topic because it is associated with sexual behaviour
[34,35]. This was echoed in our study: practitioners
observed that HPV infection is a sensitive topic for
patients and gave this as a reason for not raising it in
consultations. While it is likely that this theme would
also emerge elsewhere, it is possible that it may be par-
ticularly strong in Ireland because of cultural and social
norms around discussing or admitting sexual behaviour.
For example, 2008 research among women in Ireland
found that there was a considerable stigma attached tohaving smears because it was seen to be an admission of
sexual activity [17,18]. Interestingly, the issue of sensitiv-
ity around HPV did not seem to be limited to patients;
practitioners’ comments about HPV infection also
revealed emotional influences. For example, they fre-
quently talked about the difficulty of raising the subject
with patients and the underlying tone of some interviews
was tentative and awkward. One might expect that
healthcare professionals would have ample experience of
dealing with sensitive topics. Therefore, it is unclear
whether there is something particularly challenging
about HPV itself or whether practitioners’ emotions are
influenced by their lack of knowledge, concerns about
their ability to deal with patients’ reactions (skills), or
other issues. Further research would be valuable to
investigate the relationship between relevant theoret-
ical constructs.Social influences
Practitioners often stated that they did not discuss HPV
with patients because they believed that patients either
did not know anything, or did not want to know any-
thing, about it. Studies in various counties have shown
that there is limited knowledge about HPV amongst
women [36-40]. However, a lack of knowledge is not
universal, and a population survey of women in Ireland
conducted in 2010 (O’Connor et al. 2010; personal com-
munication) found that 44% had heard of HPV infection
and 55% had heard of HPV vaccination. In addition,
qualitative research among women in Ireland in 2008
found that, on learning about the link between HPV and
cervical cancer, women were shocked, angry, and felt
that this was a ‘secret’ that the medical community had
kept from them [18,19]. Women also wanted to know
more about HPV. Thus, it may be counterproductive for
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HPV or are not motivated to discuss it. Our findings
also suggest that influencing practitioners’ perceptions
about patient influences (e.g., a lack of desire to know
about HPV) might increase the behaviour. We also
found that practitioners’ reported that HPV infection is
difficult to explain in a way that patients understand
(skill), and there is insufficient time in consultations
(environmental context and resources) suggesting that
other factors interact with perceived social influences in
relation to discussing HPV infection. It is also possible
that reasons cited by practitioners for not discussing
HPV infection may mask a reluctance of practitioners
themselves to discuss the topic.Beliefs about consequences
Beliefs about consequences was important in relation to
both HPV infection and vaccination. For HPV infection,
only negative consequences were raised, while for HPV
vaccination, both positive and negative consequences
emerged, with practitioners tending to discuss one
aspect or the other. Of note, practitioners who raised
concerns regarding vaccination safety were generally
unaware that the death of a schoolgirl in the UK follow-
ing vaccination was subsequently found to be unrelated
to the vaccination [41]. The polarized views about the
consequences of vaccination may reflect the fact that the
HPV evidence-base is still evolving, particularly in rela-
tion to long-term efficacy and safety [12]. However, the
fact that this domain was important suggests that influ-
encing practitioners’ beliefs about consequences might
influence their behaviours in relation to HPV.
Knowledge
Previous research found gaps in doctors’ HPV infection
and vaccination knowledge [22,23]. This study confirms
these and shows that primary care nurses also have
limitations in their knowledge. Knowledge gaps were
reported directly by practitioners, in their own words,
and also became apparent through their responses to the
clinical scenarios, meaning that practitioners varied in
the extent to which they perceived that their knowledge
was limited. Practitioners also described difficulties in
keeping abreast of the clinical evidence; this has been
identified as a barrier to primary care practice and
patient care in other clinical areas [42-44].
Knowledge limitations, and the uncertainty expressed
about current evidence, are perhaps not surprising given
that the HPV vaccination programme in Ireland started
only recently, data continues to emerge from the HPV
vaccination trials [12], HPV testing is both relatively new
and rare in primary care, and no clinical guidelines are
in place. However, high-risk HPV infection wasestablished as a necessary cause of cervical cancer a dec-
ade ago [2], and the key features of HPV infection have
been clear for several years. For example, the same
answers would be correct nowadays for all of the ques-
tions contained in the instrument developed by Jain
et al. in 2004 to assess practitioners’ HPV infection
knowledge [22]. Hence, there are probably fewer uncer-
tainties in the evidence-base around HPV infection, and
it is not as rapidly evolving, as practitioners perceive.
It was noteworthy that CervicalCheck was seen as a
trusted source for information on issues beyond smear
taking (i.e., around HPV) given that CervicalCheck had
not produced formal advice or practice guidelines in
relation to HPV in primary care. While this finding
suggests that practitioners hold CervicalCheck in high
esteem, it probably also reflects the fact that HPV infor-
mation is perceived not to be available elsewhere, or
at least not from a source that practitioners view
as trustworthy.
For many practitioners, uncertainty around evidence
flowed into an uncertainty about what to do in practice.
Our analysis further suggested that this might have
influenced how practitioners felt about the clinical areas
and this, in turn, impacted on their practice (e.g., leading
to avoidance). We also found a contrast between know-
ledge and beliefs about capabilities. Some GPs especially
were high in self-efficacy although it was clear from the
interviews that they lacked knowledge. This suggests
knowledge to be a necessary intervention target, but
shows that it is unlikely to influence clinical practice if
other relevant key variables are not taken into account.
Further research thus needs to establish how knowledge
and other potentially relevant factors suggested in this
study act together to influence behaviour.
Reflections on using the TDF
This study was the first stage in the development of an
intervention, a process being guided by the MRC Frame-
work for the Development of Complex Interventions
[45,46]. Some investigators have observed that develop-
ing an intervention is time-consuming [47] and all stud-
ies, including ATHENS, have resource limitations. We
applied the TDF, within a framework analysis approach
[32], to analyse qualitative data collected using a topic
guide not specifically based on the TDF domains. One
of the main advantages of this was that the analysis was
focused and efficient. The structured approach afforded
by using the TDF to pre-define themes facilitated cross-
checking the allocation of subthemes to themes and
reaching analytical consensus. No influences on practi-
tioners’ behaviours arose in the interviews that could
not be classified according to the TDF, underlining the
comprehensiveness of the framework. The possibility
cannot be excluded that if a less structured analytical
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tice and experience might have emerged, but this risk is
minimised by the wide range of psychological constructs
included in the TDF. Equally, it is possible that a differ-
ent analytical approach would have resulted in the
themes being labelled or interpreted somewhat differ-
ently; this, however, could apply to almost all qualita-
tive studies. A further strength of using the TDF was
that our analysis was not prematurely confined to a
particular psychological theory. This was, of course, a
major rationale for the development of the TDF [30].
In our context, we had little a priori information on
which to base the selection of appropriate theories.
In view of the number of theoretical construct domains
that emerged in relation to each clinical area, it was
clear that using the TDF had strengthened the study:
had we focussed from the outset on one or two theories
(e.g., Theory of Planned Behaviour) [29], it is likely
that we would have missed important influences on
clinical behaviour and this would have impacted on
the likely effectiveness of any intervention subse-
quently developed.
The evidence base for HPV testing in cervical screen-
ing and efficacy of HPV vaccination continues to
develop and to date there are no guidelines on HPV in
primary care in Ireland. One potential limitation of the
TDF is that it was designed for use in situations in which
clear evidence-based clinical practice guidelines are in
place. It has previously been suggested that the theoret-
ical domains might be of less utility in situations without
clear-cut guidelines or in which the evidence base is
somewhat uncertain, because the effect of potential pre-
dictors might be overwhelmed by variations in attitudes
[48]. This did not seem to be an issue in our context.
Although there were variations in practice and attitudes,
between nine and 12 of the domains were relevant to
each clinical behaviour.
A further potential limitation is that the TDF does not
specify relationships between the construct domains.
Our synthesis and interpretation suggested that there
may be links between psychological constructs in influ-
encing behaviour (e.g., between beliefs about capabilities
and knowledge), but the TDF does not enable formal
investigation of these links. Nor were we able to deter-
mine, other than in a qualitative way, which of the
domains were likely to be the most important drivers of
clinical behaviour. However, these limitations were in
part a function of the qualitative study design, rather
than the TDF per se. This study was the first step in an
intervention development process and was intended to
be hypothesis generating rather than hypothesis testing.
Hence, we chose qualitative methods to provide a
detailed picture of roles and responsibilities in clinical
practice around cervical cancer prevention and to identifywhich domains may play a role. The next stage in the de-
velopment process is a quantitative study in which we will
determine the frequency of the behaviours of interest,
identify the most important predictors of behaviours and
investigate inter-relationships between domains and con-
structs predicting these behaviours. We have used the
results reported here to design a questionnaire for this
quantitative study. This proved to be a very efficient
method of questionnaire development. Questions were
included covering the domains and subthemes that were
reported by more than one practitioner; this helped in fo-
cusing and limiting the length of the questionnaire, and
should reduce the possibility of redundant questions. The
language used by interview participants was used to form
question stems, which should enhance face validity. The
questionnaire study is currently under way.
Conclusions
The findings of this study confirm the need for an inter-
vention to support primary care practitioners in their
HPV-related practice. This intervention should target
both male and female practitioners and should be direc-
ted towards discussing HPV infection with female
patients, offering or recommending HPV vaccination to
appropriate patients and answering patients’ questions
around HPV testing. Such an intervention is more
likely to be effective if it is aimed at a range of theoret-
ical domains. The TDF proved valuable in analysing
qualitative data collected using a topic guide not specif-
ically designed to capture TDF domains, and under-
standing clinical behaviours in an area with an evolving
evidence-base.
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